SeraCare Accuvert HCV Seroconversion Panels PHV924, PHV925 and PHV926

SeraCare Life Sciences has launched three Hepatitis C Accuvert seroconversion panels designed to help diagnostics manufacturers and clinical labs evaluate, monitor and troubleshoot test and staff performance.

The panels provide manufacturers with material from a variety of donor genotypes and recent collection periods. Each panel demonstrates how a single donor responds in the presence of the disease during the collection period, with a graphical depiction of seroconversion. Product data sheets also offer comparative data that is valuable in reviewing test results from a number of assays.

The Hepatitis C Accuvert seroconversion panels include: HCV Seroconversion Panel PHV924, providing undiluted plasma samples from a single male donor of genotype 2b, drawn over an 88-day period in 2008; HCV Seroconversion Panel PHV925, providing undiluted plasma samples from a single male donor of genotype 1a, drawn over a 27-day period in 2008; HCV Seroconversion Panel PHV926, providing undiluted plasma samples from a single male donor of genotype 3a, drawn over a 14-day period in 2009.